本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Humacyte, Inc.

2.28
-0.1200-5.00%
盘后2.24-0.0400-1.75%19:57 EDT
成交量:580.59万
成交额:1,322.56万
市值:3.54亿
市盈率:-3.52
高:2.31
开:2.20
低:2.19
收:2.40
数据加载中...
2024/05/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/10

重要事件披露

Form 8-K - Current report
2024/03/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/22

重要事件披露

Form 8-K - Current report
2024/03/08

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/07

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/04

重要事件披露

Form 8-K - Current report
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/09

重要事件披露

Form 8-K - Current report
2023/12/12

重要事件披露

Form 8-K - Current report
2023/12/01

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/15

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/12

重要事件披露

Form 8-K - Current report
2023/08/22

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities